...
首页> 外文期刊>Journal of Parasitology and Vector Biology >Comparative analysis of genomic DNA amplification yield for Plasmodium falciparum extracted from urine, saliva and blood
【24h】

Comparative analysis of genomic DNA amplification yield for Plasmodium falciparum extracted from urine, saliva and blood

机译:从尿液,唾液和血液中提取的恶性疟原虫基因组DNA扩增产量的比较分析

获取原文
           

摘要

Malaria treatment and/or management remains an essential element as well as strategy controlling this pathology. Since 2005, C?te d'Ivoire has adopted Artemisinin-based Combination Therapies (ACTs) as first-line drugs to treat uncomplicated malaria. Malaria diagnostic mechanism involves blood sampling by using finger prick collection or venipuncture which requires very strict aseptic conditions. However, some groups of people refuse to cooperate with these diagnostic methods because of (i) cultural believe forbidding seeing of blood and (ii) trauma related to the needle sting. Here, two non-invasive sampling and one invasive methods to diagnose malaria using molecular method were tried. Blood, urine and saliva samples were collected in three different localities from patients above 2 years of age having simple Plasmodium falciparum malaria confirmed by microscopy. Then, P. falciparum genomic DNA was extracted and amplified through Pfcrt, Pfdhfr-ts, and PfK13 propeller genes specific primers. Amplification products were processed by electrophoresis and analyzed according to blood, saliva and urine samples. A multivariate statistical analysis based on R software was carried out with the purpose to assess the aptitude and/or performance of each analyzed biological samples in malaria molecular diagnosis procedure. The results revealed the presence of P. falciparum DNA in urine (27.57%) of the amplification products, saliva (40.21%) and blood (91.55%). Assuming blood sample as benchmark, the statistical analysis exhibited saliva as a suitable biological sample fitting for malaria molecular diagnosis (p-value ≤ 0.05), and suspected urine as a source of variability analyzing the aforementioned described malaria patient population excluding the latter as a reliable sample in malaria molecular diagnosis. The same results exhibited Pfdhfr and PfK13 propeller genes amplified from saliva as satisfactory molecular markers for chemo-resistance. The findings suggested P. falciparum genomic DNA amplification from saliva sample as closer in comparison to blood and proposed the former (saliva) as an alternative to blood in malaria molecular diagnosis process.
机译:疟疾的治疗和/或管理仍然是控制该病理的基本要素以及策略。自2005年以来,科特迪瓦已采用基于青蒿素的联合疗法(ACTs)作为治疗单纯性疟疾的一线药物。疟疾诊断机制涉及通过采血或静脉穿刺采血,这需要非常严格的无菌条件。但是,由于(i)出于文化原因,禁止看到血液以及(ii)与针刺有关的创伤,一些人拒绝与这些诊断方法配合使用。在这里,尝试了两种使用分子方法诊断疟疾的非侵入性采样和一种侵入性方法。从两个年龄在2岁以上且经显微镜检查证实患有单纯性恶性疟原虫的患者中,从三个不同的地方收集血液,尿液和唾液样本。然后,提取恶性疟原虫基因组DNA,并通过Pfcrt,Pfdhfr-ts和PfK13螺旋桨基因特异性引物进行扩增。扩增产物通过电泳进行处理,并根据血液,唾液和尿液样本进行分析。进行了基于R软件的多元统计分析,目的是评估疟疾分子诊断程序中每个分析的生物样品的适应性和/或性能。结果显示,扩增产物的尿液(27.57%),唾液(40.21%)和血液(91.55%)中存在恶性疟原虫DNA。假设以血液样本为基准,统计分析显示唾液是适合进行疟疾分子诊断的生物样本(p值≤0.05),而怀疑尿液是分析上述疟疾患者群体(不包括后者)的可变性来源。疟疾分子诊断中的样本。相同的结果显示从唾液中扩增的Pfdhfr和PfK13螺旋桨基因是令人满意的抗化学分子标记。研究结果表明唾液样品中恶性疟原虫基因组DNA扩增与血液相比更近,并提出在疟疾分子诊断过程中前者(唾液)可替代血液。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号